Creative Medical Technology Holdings, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-12-31 was $1.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-09-30 was $153.98K, a 64.04% decline year-over-year.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-06-30 was $341.79K, a 34.19% increase year-over-year.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-03-31 was $887.56K, a 153.19% increase year-over-year.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $1.38M, a 1.22% increase from fiscal 2020.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $1.37M, a 8.96% decline from fiscal 2019.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $1.50M, a 49.43% increase from fiscal 2018.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $1.00M, a 219.90% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2021-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.38M 10-K · filed 2023-03-31 |
| 2021-09-30 | $153.98K 10-Q · filed 2022-11-10 | $1.72M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $341.79K 10-Q · filed 2022-08-12 | $1.99M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $887.56K 10-Q · filed 2022-05-13 | $1.90M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $333.29K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.37M 10-K · filed 2022-03-30 |
| 2020-09-30 | $428.16K 10-Q · filed 2021-11-15 | $1.18M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $254.71K 10-Q · filed 2021-08-16 | $1.45M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $350.55K 10-Q · filed 2021-05-17 | $1.68M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $143.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $1.50M 10-K · filed 2021-03-17 |
| 2019-09-30 | $697.88K 10-Q · filed 2020-11-13 | $1.49M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $491.23K 10-Q · filed 2019-08-13 | $976.66K derived: sum of 4 quarters · filed 2020-05-15 |
| 2019-03-31 | $168.97K 10-Q · filed 2020-05-15 | $955.81K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $1.00M 10-K · filed 2020-04-06 |
| 2018-09-30 | $181.45K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $470.38K 10-Q · filed 2019-08-13 | |
| 2018-03-31 | $217.85K 10-Q · filed 2019-05-20 | |
| 2017-12-31 | $314.07K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |